Our Medicines

With a focus on areas of significant unmet medical need, Bristol-Myers Squibb develops and delivers medicines that treat cancer, cardiovascular disease, diabetes, psychiatric disorders, rheumatoid arthritis and infectious diseases such as HIV/AIDS and hepatitis B.

Key Products (Australia)

Brand Name Generic Name
ABILIFYTM (aripiprazole)
AVAPRO® (irbesartan)
AVAPRO HCT® (irbesartan and hydrochlorothiazide)
BARACLUDE® (entecavir)
DUOCOVER® (clopidogrel hydrogen sulphate and aspirin)
ELIQUIS® (apixaban)
ISCOVER® (clopidogrel hydrogen sulfate)
ONGLYZA® (saxagliptin)
ORENCIA® (abatacept)
PERFALGAN® (paracetamol)
REYATAZ® (atazanavir sulfate)
SPRYCEL® (dasatinib)
YERVOY® (ipilimumab)

Consumer Medicine Information

Consumer Medicine Information, or CMI, provides clear, easy-to-understand information to consumers and their carers about how to use their medicines.

A CMI will outline:

  • What the medicine is used for
  • How it works
  • How to use it
  • Its ingredients
  • Its known side effects
  • Whether it has any interaction with other medicines

For more information, please contact your doctor or pharmacist.

Consumer Medicine Information leaflets for key Bristol-Myers Squibb products available in Australia are included on this page. Importantly, this information is intended for use in Australia only and does not replace advice from a healthcare professional.

Consumer Medicine Information about our products can also be obtained from Bristol-Myers Squibb Medical Enquiries.

Toll free number (Australia only): 1800 067 567

Email: MedInfo.Australia@bms.com

9.00am - 5.00pm (Mon to Fri ex Victorian public holidays)

Disclaimer: Please refer to the full prescribing information approved by the relevant governmental authority of the country where you are located and consult your physician for professional medical advice and services.